Microcoil embolisation for ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy

Mihai Iacob1, Florina Pinte, Ion Tintoiu

  • 1Army Center for Cardiovascular Diseases, Bucharest, Romania.

Kardiologia Polska
|April 21, 2005
PubMed

Insights

Microcoil embolization effectively treats hypertrophic obstructive cardiomyopathy (HOCM) by occluding septal arteries. This safe procedure reduces pressure gradients and improves symptoms without alcohol-related risks.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Devices

Background:

  • Hypertrophic obstructive cardiomyopathy (HOCM) is a condition characterized by thickened heart muscle.
  • Percutaneous transcatheter occlusion using ethanol injection has been an established treatment for HOCM.
  • Septal artery embolization offers an alternative approach to managing HOCM.

Purpose of the Study:

  • To evaluate the feasibility and efficiency of septal artery embolization using microcoils in patients with HOCM.
  • To assess the impact of microcoil embolization on intraventricular pressure gradients.
  • To compare the safety and efficacy of microcoil embolization with ethanol injection.

Main Methods:

  • Microcoils were delivered via a coaxial balloon catheter into the target septal arteries.
  • Complete flow obstruction was achieved using 0.018"-straight microcoils.
  • Intraventricular pressure gradients were measured pre- and post-procedure; coronary angiography confirmed occlusion.

Main Results:

  • Seven symptomatic HOCM patients (NYHA class III/IV) were treated successfully without complications.
  • Mean pressure gradient decreased from 72 mmHg to 30 mmHg during the procedure and 34 mmHg post-procedure.
  • All patients showed clinical improvement (NYHA class I/II) with no need for permanent pacing.

Conclusions:

  • Microcoil embolization is a safe and effective transcatheter method for ablating septal hypertrophy in HOCM.
  • This technique induces myocardial necrosis without alcohol's toxic effects.
  • It reduces risks associated with ethanol injection, such as permanent pacemaker implantation or off-target effects.
Abstract

Related Concept Videos